Literature DB >> 2978926

Anti-interleukin-2 receptor (IL-2R) antibody against rejection of organ grafts.

J W Kupiec-Weglinski1, W Padberg, L C Uhteg, E Towpik, R H Lord, L Ma, T Diamantstein, T B Strom, N L Tilney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2978926

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

Review 1.  Routes to transplant tolerance versus rejection; the role of cytokines.

Authors:  Patrick T Walsh; Terry B Strom; Laurence A Turka
Journal:  Immunity       Date:  2004-02       Impact factor: 31.745

2.  Anti-IL-2 receptor monoclonal antibody AMT-13 increases soluble IL-2 receptor levels in vivo.

Authors:  K Burkhardt; T E Mandel; T Diamantstein; M S Loughnan
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

3.  Anti-interleukin 2 receptor monoclonal antibodies spare phenotypically distinct T suppressor cells in vivo and exert synergistic biological effects.

Authors:  R Di Stefano; A Mouzaki; D Araneda; T Diamantstein; N L Tilney; J W Kupiec-Weglinski
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.